Type 1 Diabetes

ADA 2018 abstracts of interest include Entresto for the Treatment of Diabetic Peripheral Neuropathy; Oral Contraceptive Associated with Postmenopausal Diabetes; Glucokinase as Adjunct Therapy in People with Type 1 Diabetes, and more.

There have been many studies that have been conducted meant to access the effect of alcohol consumption on diabetes - some suggesting that a moderate intake contributes to the risk for diabetes, and others suggesting moderate alcohol is a protective for type 2 diabetes.

Multi-center study compares closed-loop device to standard open-loop system in a home setting.

One-year, randomized study shows lower HbA1c, blood glucose, blood pressure and body weight without significant increase in hypoglycemia.

DEPICT-2 study of more than 800 people worldwide indicates positive results without added risk of severe hypoglycemia, but slight increase in DKA events.

The FDA approved the 90-day version of the implantable CGM Sensor.

A dual-hormone, artificial pancreas delivering rapid insulin and the drug pramlintide improved glucose management and reduced glucose variability in adults with type 1 compared to an insulin-only, first-generation artificial pancreas.

Mini-dose glucagon might be a better option for treating exercise-induced hypoglycemia than carbohydrate ingestion or insulin dose reduction.

Data from DIAMOND trial to help determine if CGM helps those with consistently high glucose.

Additional conditions more likely in those diagnosed later in life.